Cite
HARVARD Citation
DeJesus, E. et al. (2020). A Phase IIa Study Evaluating Safety, Pharmacokinetics, and Antiviral Activity of GSK2838232, a Novel, Second-generation Maturation Inhibitor, in Participants With Human Immunodeficiency Virus Type 1 Infection. Clinical infectious diseases. pp. 1255-1262. [Online].